SSE15206 is primarily used in research settings as a selective inhibitor of sodium channels, particularly Nav1.7, which is implicated in pain signaling pathways. It serves as a valuable tool compound for studying the role of voltage-gated sodium channels in neuronal excitability and pain transmission. Due to its potency and selectivity, it is employed in preclinical studies to evaluate potential analgesic effects without affecting other sodium channel subtypes significantly. Its application supports the development of novel pain therapeutics, especially for conditions involving neuropathic or chronic pain. Additionally, SSE15206 is utilized in electrophysiological experiments to modulate channel activity and investigate ion channel function in cellular models.